Theravance Biopharma (TBPH) Net Margin Growth (3y) (2016 - 2026)
Theravance Biopharma (TBPH) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,283.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 4,144.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Theravance Biopharma | 864.82 Mn | 470.15 Mn | - | 18,012.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,012.00 |
| Dec 31, 2025 | 3,584.00 |
| Sep 30, 2025 | -742,783.00 |
| Jun 30, 2025 | 4,301.00 |
| Mar 31, 2025 | -20,640.00 |
| Dec 31, 2024 | -25,528.00 |
| Sep 30, 2024 | -23,143.00 |
| Jun 30, 2024 | -21,236.00 |
| Mar 31, 2024 | -12,820.00 |
| Dec 31, 2023 | 37,152.00 |
| Sep 30, 2023 | 34,634.00 |
| Jun 30, 2023 | 30,523.00 |
| Mar 31, 2023 | 20,995.00 |
| Dec 31, 2022 | 5,393.00 |
| Sep 30, 2022 | 791,611.00 |
| Jun 30, 2022 | 24,010.00 |
| Mar 31, 2022 | 147,784.00 |
| Dec 31, 2021 | 49,114.00 |
| Sep 30, 2021 | 61,909.00 |
| Jun 30, 2021 | 27,029.00 |